Unlock instant, AI-driven research and patent intelligence for your innovation.

Polymer precursors of radiolabeled compounds, and methods of making and using the same

a radiolabeled compound and polymer precursor technology, applied in the direction of peptides, isotope introduction of acyclic/carbocyclic compounds, organic compounds of the group 3/13 element, etc., can solve the problems of short shelf life, chemical purity and isotopic purity, and the presence of toxic tin by-products,

Inactive Publication Date: 2006-05-18
UNIV OF WESTERN ONTARIO
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This approach enables the rapid and efficient synthesis of radiolabeled compounds with high specific activity, free from toxic impurities, suitable for medical imaging and therapeutic applications, including cancer treatment and imaging agents for breast cancer, sigma receptors, and renal imaging.

Problems solved by technology

While this process yields isotopically pure products, toxic tin by-products remain and must be separated before the radiolabeled molecules can be used.
Furthermore, the unstable nature of radiolabeled molecules and their precursors lead to a short shelf life.
This method presents a similar problem of chemical purity and isotopic purity.
The separation of radiolabeled material from non-radiolabeled material is particularly difficult since the protein or peptide is very large and the tag represents only a minor structural modification.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polymer precursors of radiolabeled compounds, and methods of making and using the same
  • Polymer precursors of radiolabeled compounds, and methods of making and using the same
  • Polymer precursors of radiolabeled compounds, and methods of making and using the same

Examples

Experimental program
Comparison scheme
Effect test

example 1

(4S,5S)-2-(3-bromophenyl)-3,4-dimethyl-5-phenyl-1,3-oxazolidine (7)

[0230] Into a one necked 250 mL round-bottom flask, equipped with a Dean-Stark trap and a condenser was placed 8.78 g (47.5 mmol) of 3-bromobenzaldehyde and 7.83 g (47.4 mmol), of (S,S)-(+)-pseudoephedrine followed by 180 mL of benzene. After reflux for 18 hrs, the benzene was removed using a rotary-evaporator, to give a yellow oil, which solidified upon standing. A white solid (mp. 73-75° C.) was obtained after recrystallization from hexanes, 14.78 g (94%).

[0231]1H NMR (CDCl3) ppm: 7.75 (s, 1H), 7.51-7.26 (m, 8H), 4.93 (s, 1H), 4.76 (d, 1H), 2.56 (m, 1H), 2.23 (s, 3H), 1.23 (d, 3H). 13C NMR ppm: 141.96, 139.91, 132.08, 130.95, 129.86, 128.37, 128.00, 126.76, 126.61, 122.50, 98.60, 86.60, 68.62, 35.12, 14.23.

example 2

(4S,5S)-2-(4-bromophenyl)-3,4-dimethyl-5-phenyl-1,3-oxazolidine (8)

[0232] In an analogous manner, 500 mg (2.7 mmol) of 4-bromobenzaldehyde, 450 mg (2.7 mmol), of (S,S)-(+)-pseudoephedrine and 40 mL of benzene were refluxed for 18 hrs. Solvent evaporation yielded a viscous yellow oil, 883 mg (98%).

[0233]1H NMR (CDCl 3): 7.42 (d, 2H), 7.35-7.20 (m, 7H), 4.82 (s, 1H), 4.65 (d, 1H), 2.45 (m, 1H), 2.09 (s, 3H), 1.12 (d, 3H). 13C NMR: 139.97, 138.53, 131.38, 129.68, 128.33, 127.94, 126.56, 122.91, 98.69, 86.50, 68.59, 35.00, 14.19.

example 3

Poly-(4S,5S)-2-(3-{dibutyl[2-(3-and 4-vinylphenyl)ethyl]stannyl}phenyl)-3,4-dimethyl-5-phenyl-1,3-oxazolidine)-co-divinylbenzene (9)

[0234] The protected 3-bromobenzaldehyde 7, (2.90 g, 8.7 mmol), was added into a three-necked 200 mL round-bottom flask, equipped with a T-bore stopcock, a rubber septum and a powder addition side arm containing 4.01 g of chlorostannane polymer 10 (˜5.9 mmol of SnCl). Under a flow of argon, 80 mL of freshly distilled dry THF was added by syringe. The flask and its contents were outgased three times at dry ice / acetone temperatures and an argon atmosphere was introduced. To the solution of 7 in THF at −78° C., n-butyllithium (3.0 mL, 7.5 mmol, 2.5 M) was added dropwise with the resultant formation of a yellow color. After 2 h at −78° C., the polymer was tipped into the THF solution, and the suspension was allowed to stir for 18 h and warm slowly to RT. To the suspension about 3 mL of methanol was added and the suspension was filtered. The solid was washe...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
volumesaaaaaaaaaa
insolubleaaaaaaaaaa
Login to View More

Abstract

One aspect of the present invention relates to novel compounds that can be used to prepare radiolabeled compounds in an effective manner. A second aspect of the present invention relates to a method of synthesizing radiolabeled compounds.

Description

RELATED APPLICATION INFORMATION [0001] This application claims the benefit of priority under 35 U.S.C. Section 119 to U.S. Provisional Patent Application 60 / 272,324, filed Mar. 2, 2001; and U.S. Provisional Patent Application 60 / 280,225, filed Mar. 30, 2001. These applications are hereby incorporated by reference in their entirety.INTRODUCTION [0002] Molecules labeled with radioactive isotopes have been used as both imaging agents in medical diagnosis as well as therapeutic agents in the treatment of cancer. Both radiolabeled small molecules and radiolabeled peptides and nucleotides have been used to diagnose tumors. In addition to their use as diagnostic tools, radiolabeled nucleosides have been used to treat tumors in mammals by injecting or infusing radiolabeled nucleosides directly to the affected site. [0003] One common method of labeling molecules with radioactive isotopes for medical use is a stannylation process. While this process yields isotopically pure products, toxic ti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K51/00C07F5/00C07F7/22G01N33/60A61K51/06C07B59/00C07C231/12C07C233/78C07K14/00C08F2/00C08F8/00C08F8/32C08F8/42
CPCA61K51/06C07B59/00C07B2200/11C07K1/042C08F8/32C08F8/42C07C231/14C07D207/06C07D211/14C07D295/13C07B59/001C07B59/002C07K1/13
Inventor HUNTER, DUNCAN H.JANABI, MUSTAFA
Owner UNIV OF WESTERN ONTARIO